Is BPC 157 Legal? Understanding Its Status and Implications Gray Market Peptides: So Much Hype, So Little Data The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette BPC 157: Experimental Peptide Creates Risk for Athletes